These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. Worldwide Atosiban versus Beta-agonists Study Group BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials. Coomarasamy A; Knox EM; Gee H; Song F; Khan KS BJOG; 2003 Dec; 110(12):1045-9. PubMed ID: 14664874 [TBL] [Abstract][Full Text] [Related]
9. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. European Atosiban Study Group Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217 [TBL] [Abstract][Full Text] [Related]
10. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. French/Australian Atosiban Investigators Group Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128 [TBL] [Abstract][Full Text] [Related]
11. Tocolytic treatment for the management of preterm labour: a systematic review. Tan TC; Devendra K; Tan LK; Tan HK Singapore Med J; 2006 May; 47(5):361-6. PubMed ID: 16645683 [TBL] [Abstract][Full Text] [Related]
12. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856 [TBL] [Abstract][Full Text] [Related]
13. Treatment of preterm labor with the oxytocin antagonist atosiban. Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103 [TBL] [Abstract][Full Text] [Related]
14. The development and introduction of anti-oxytocic tocolytics. Lamont RF BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125 [TBL] [Abstract][Full Text] [Related]
15. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation. Wex J; Connolly M; Rath W BMC Pregnancy Childbirth; 2009 Jun; 9():23. PubMed ID: 19538754 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women. Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630 [TBL] [Abstract][Full Text] [Related]
17. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour]. Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742 [TBL] [Abstract][Full Text] [Related]
19. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women. Shim JY; Park YW; Yoon BH; Cho YK; Yang JH; Lee Y; Kim A BJOG; 2006 Nov; 113(11):1228-34. PubMed ID: 16978233 [TBL] [Abstract][Full Text] [Related]